Education
Jean received a Masters Degree in Electrical Engineering from the École Supérieure d"Électricité and a Doctor of Philosophy in Economics from the Sorbonne.
Jean received a Masters Degree in Electrical Engineering from the École Supérieure d"Électricité and a Doctor of Philosophy in Economics from the Sorbonne.
Deleage began investing in venture capital in 1971 with the formation of Sofinnova (officially founded in 1972). Five years later, in 1976, Deleage founded Sofinnova’s United States business, based in San Francisco, Sofinnova, Incorporated. In 1997, when Sofinnova split into two firms, the United States business would come to be known as Sofinnova Ventures.
In 1979, Deleage, who worked left Sofinnova to co-found a new, bi-coastal venture capital firm Burr, Egan, Deleage & Company
(BEDCO), with Craig Burr and William P. Egan, who had worked together at TA Associates. BEDCO was one of the largest and most active venture capital firms in the 1980s and early 1990s.
Deleage and BEDCO were early investors in a number of notable venture backed companies including Cephalon, Chiron and Genentech. Additionally, Deleage facilitated a significant partnership between BEDCO and Sofinnova, leading to a number of co-investments.
BEDCO invested in information technology, communications, and healthcare/biotechnology companies, and at its zenith managed $700 million in assets.
In 1984, Doctor Deleage was awarded the Ordre National du Merite.
Deleage was a member of the board of directors of Rigel Pharmaceuticals, Incorporated., TorreyPines Therapeutics, Incorporated. and several private companies.